Drug General Information
Drug ID	D07ZZD
Former ID	DNC014181
Drug Name	4-Benzoxazo-2-yl-1,4-diazabicyclo[3.2.2]nonane
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530609]
Structure		Download 2D MOL 3D MOL
Formula	C14H17N3O
Canonical SMILES	C1CN2CCC1N(CC2)C3=NC4=CC=CC=C4O3
InChI	1S/C14H17N3O/c1-2-4-13-12(3-1)15-14(18-13)17-10-9-16-7-5-11(17)6-8-16/h1-4,11H,5-10H2
InChIKey	CXJLWJAYGMWLRR-UHFFFAOYSA-N
PubChem Compound ID	9794818
Target and Pathway
Target(s)	5-hydroxytryptamine receptor 3A	Target Info	Inhibitor	[530609]
KEGG Pathway	Serotonergic synapse
NetPath Pathway	IL2 Signaling Pathway
PANTHER Pathway	5HT3 type receptor mediated signaling pathway
Reactome	Ligand-gated ion channel transport
WikiPathways	SIDS Susceptibility Pathways
	Iron uptake and transport
References
Ref 530609	J Med Chem. 2010 Feb 11;53(3):1222-37.Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.
Ref 530609	J Med Chem. 2010 Feb 11;53(3):1222-37.Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.